Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
CA 2032827 A1 · Owner: Liang, Chi-Dean · Inventors: Mckearn, John P.; Liang, Chi-Dean; Mueller, Richard A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Case 2567/2, PHENYLACETONITRILEALKYLAMINOALKYL-ORTHO-SUBSTITUTED ARYL COMPOUNDS AS IMMUNOSUPPRESSIVES, ABSTRACT A class of substituted phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds having immunosuppressive properties is described. Compounds of this class would be useful in reducing recipient rejection of transplanted organs and for treatment of autoimmune or inflammatory diseases. Compounds of particular interest are of the formula, wherein m is one or two; wherein n is a number selected from one to five, inclusive; wherein R1 is selected from hydrido alkyl, hydroxyalkyl, cycloalkyl, cycloalkylalkyl alkoxyalkyl, alkenyl and alkynyl; wherein R6 is selected from …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 20, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 20, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 20, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.